Nebius Stock: A Rotterdam Megaproject, a Rival's Anthropic Win, and the Funding Scrutiny Tying Them Together

Nebius slips 2.9% amid a selloff in debt-financed AI infrastructure, as investors weigh its 600MW Rotterdam plan, IREN's Anthropic deal and the Inferize buy.

Two threads are pulling at Nebius investors this week, and they run in opposite directions. One is a planned 600-megawatt AI data center in Rotterdam that the company signaled it intends to anchor. The other is a market that has suddenly turned picky about how such buildouts get paid for.

The stock slipped 2.9% on the day as a selloff in debt-financed AI infrastructure names dragged Nebius down alongside CoreWeave. Broader cloud software companies escaped the worst of it, a split that says a lot about where the anxiety sits: investors are questioning the financing requirements behind capital-hungry AI expansion, not reacting to any fresh operational disclosure from Nebius itself.

The funding question moves to the front

That pressure did not start today. Media reports on the prior session already tied the persistent weight on Nebius to doubts about AI valuations and the economics of capital-intensive cloud expansion. Reports that OpenAI's annualized revenue came in below market expectations added to the mood. Notably, no new negative company announcement was cited as the immediate trigger.

So Nebius shareholders are left holding two questions at once: how large is the growth opportunity, and under what economic conditions can it actually be unlocked? Today's sector move makes clear that the capital requirement is carrying more weight in the market's calculus. It is not, however, evidence that Nebius has altered its business targets.

How concrete those expansion plans are became clearer on Monday, when Nebius disclosed a letter of intent with VOLT. Under the arrangement, Nebius would take a substantial share of the capacity at a planned AI data center in Rotterdam, a site designed to reach 600 megawatts. VOLT would develop the facility and install the chips, which Nebius would lease over multiple years. Financial terms were not released, and a definitive contract has yet to follow — meaning the agreement describes a planned expansion, not fully negotiated economics.

A rival's win, and what it does and doesn't prove

Competitive noise has been building in parallel. IREN's disclosed multi-year cloud computing contract with Anthropic fed directly into concerns about Nebius's position, and coverage of Nebius linked that deal to competitive worries. A weak technology sector and unease over AI infrastructure spending did the rest.

The distinction matters. A soft tech tape says little about how well Nebius executes on its own opportunities. A rival's contract, by contrast, goes straight to the question of who is actually capturing demand. Dismissing the pressure as mere bad sentiment is too convenient — but the IREN deal proves neither a lost order for Nebius nor a deterioration in its contract terms. It shows a competitor winning. Reading a negative verdict on Nebius's entire business into that would be as hasty as ignoring the competitive question altogether. The prior session's 1.9% decline fits the described unease but does not substitute for an assessment of the business consequences.

Inferize as the tangible counter

Nebius does have a concrete answer in the works. On October 1, the company announced its acquisition of Inferize, folding that firm's inference-optimization technology and its team into Nebius Token Factory, according to company statements. Transaction terms were not disclosed.

That is a more substantive response to competitive pressure than simply pointing to a growing AI market: it brings technology and personnel in-house, a concrete step rather than a statement of intent. Even so, the move should not be overread. No specific incremental revenue follows from the acquisition alone, nor a demonstrated edge over IREN. Without published terms, there is also no way to gauge the financial burden Nebius is taking on. The strategic direction is more persuasive than any economic effect claimed today.

Where the analysts and insiders stand

A bullish counterweight arrived on October 7, when Rosenblatt Securities initiated coverage of Nebius with a buy rating and a $304 price target — a call that stands against the market's more skeptical posture. Media reports pegged analyst John McPeake's initiation to October 8. Either way, the vote represents a positive assessment, not a proven business result, and after a competitor's win a price target should not stand in for a review of operational progress.

Sentiment also took a hit from insider-sale concerns flagged in the prior session's coverage. COO Ophir Nave reported selling 500,000 Class A shares on October 5, per a Form 4 filing. The sale, however, was executed under a Rule 10b5-1 plan established back in May — a timeline that belongs in any assessment of the transaction. Today's price pressure therefore cannot be read cleanly as a reaction to a spontaneous decision by the executive.

The demand signal underneath

There is also a warning light on the customer side of the AI market. Reuters reported on October 8 that OpenAI told investors its annualized revenue for September was nearly $50 billion, after having previously held out close to $70 billion.

Those are not Nebius revenue figures, so the shortfall does not justify an immediate revision to Nebius's own business expectations. It does, however, argue against assuming that every growth expectation in the AI complex will automatically be met.

Weighed together, Nebius deserves neither blanket distrust nor a vote of confidence earned purely on its AI theme. The Inferize deal reflects an attempt to differentiate on technology. The IREN contract sharpens the question of competitive position. And the Rotterdam letter of intent shows ambition at scale — while the market, this week at least, is asking who pays for it. Concrete progress in Nebius's own offerings should count for more than optimistic price targets, and that is the yardstick by which confidence in the stock ought to be measured.